Healthcare Team May Be Latest Creatures Suspended In Formaldehyde And Put On Display In SAC Capital Lobby

Author:
Updated:
Original:

SAC Capital Advisors may have a one-day paper loss of about $196 million from its stake in Dendreon Corp. (DNDN), the drugmaker that plunged the most ever after it withdrew its 2011 revenue estimate. SAC Capital owned 8.2 million shares of Seattle-based Dendreon as of March 31, making it the biggest shareholder, according to a regulatory filing. Dendreon fell 67 percent, or $23.87, to $11.97 at 3:15 p.m. New York time in Nasdaq Stock Market trading, the largest decline since its initial public offering in June 2000. [Bloomberg]

Related